Newer glucose-lowering drugs and risk of dementia: A systematic review and meta-analysis of observational studies.

导出 OA

翻译打印收藏纠错

第一作者： Huilin,Tang

第一单位： Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA.

作者： Huilin,Tang ^[1] ; Hui,Shao ^[2] ; C Elizabeth,Shaaban ^[3] ; Keming,Yang ^[4] ; Joshua,Brown ^[2] ; Stephen,Anton ^[5] ; Yonghui,Wu ^[6] ; Adam,Bress ^[7] ; William T,Donahoo ^[8] ; Steven T,DeKosky ^[9] ; Jiang,Bian ^[6] ; Jingchuan,Guo ^[2]

作者单位： Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA. ^[1] Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA.;Center for Drug Evaluation and Safety, University of Florida, Gainesville, Florida, USA. ^[2] Department of Epidemiology, School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. ^[3] Clinical and Translational Epidemiology Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. ^[4] Department of Aging and Geriatric Research, College of Medicine, University of Florida, Gainesville, Florida, USA.;Department of Clinical and Health Psychology, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA. ^[5] Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, USA. ^[6] Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah, Salt Lake City, Utah, USA. ^[7] Division of Endocrinology, Diabetes and Metabolism, College of Medicine, University of Florida, Gainesville, Florida, USA. ^[8] Department of Neurology and McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, Florida, USA.;1Florida Alzheimer's Disease Research Center (ADRC), University of Florida, Gainesville, Florida, USA. ^[9]

关键词 DPP-4 inhibitors GLP-1RAs SGLT2 inhibitors dementia type 2 diabetes

主题词人类(Humans);糖尿病, 2型(Diabetes Mellitus, Type 2);降血糖药(Hypoglycemic Agents);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors);葡萄糖(Glucose);痴呆(Dementia)

DOI 10.1111/jgs.18306

PMID 36821780

发布时间 2024-07-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交